Ron Laskey: still discovering new lands  by Vines, Gail
Profile
Ron Laskey: still
discovering new lands
Gail Vines
Ron Laskey — soon to head a new
institute in Cambridge, UK, devoted
to the molecular biology of cancer —
is probably one of the few scientists
to derive inspiration from the French
existentialist André Gide. Pinned on
the notice board above Laskey’s
desk, alongside holiday snaps of his
family climbing in the French Alps, is
a quotation from Gide: “One does
not discover new lands without
consenting to lose sight of the shore
for a very long time.”
Ask Laskey, 53, for the secret of
his sustained scientific success, and
he’s liable to reply: “bungling
incompetence.” Pressed, he
elaborates: “I don’t plan a particular
track; I like stumbling along with my
eyes open. Funding bodies expect
you to have a clear vision, but I do
not necessarily go in the direction I
initially pointed.” Some of his best
results, he says, arose from
experiments that didn’t go smoothly,
encouraging him to explore “tangents
that proved to be productive.” He
advises his students above all to
“take note of your results when
experiments appear to have gone
wrong. Open your mind to things
you weren’t looking for.”
In Laskey’s hands, it’s a research
philosophy that works remarkably
well. He has made “seminal
contributions,” colleagues say, in areas
as seemingly disparate as cloning,
DNA replication and the targeting of
nuclear proteins. “At times his
research could seem slightly chaotic”
one former student remarks. “With so
many things going on at once, trying
to pin him down was difficult; a quick
answer was not possible.”
Yet time and again he has
produced stunning results, “findings
that really surprise you.” Beneath a
conservative demeanour lurks “an
intellectual risk-taker, though you
wouldn’t think it to talk to him.”
The day I meet Laskey, his
cautious exterior is to the fore — he
is still wincing from his first brush
with the popular media. A national
newspaper had just claimed
infallibility for his team’s new
screening test for cervical cancer, a
by-product of years of basic research
into how cells divide. “Infallible is a
word that no respectable scientist
would ever use,” Laskey notes
sharply. He is resigned, however, to
more media exposure in the future,
as co-director with clinician Bruce
Ponder of a new institute funded
primarily by the Medical Research
Council and the Cancer Research
Campaign and designed to bridge
the gap between basic research and
clinical practice in cancer treatment.
In recent years, Laskey has proved
his mettle as a scientific
administrator, deploying what one
colleague called his “tremendous
work capacity and staggering grasp of
the literature” to good effect. 
As a teacher, Laskey also shines.
“He is a superb lecturer,” says one
colleague. His secret, this time, is
humour. “I am a firm believer in the
role of humour in teaching,” he says.
“After all, it’s in everybody’s interest
that people keep awake.” Marking
exams, he notices that the details
that surround the humorous
anecdotes he tells come back much
more clearly than all the rest: “I’m
convinced that it has an important
role in communication.”
He brings his undergraduate
lecture series to a close with a musical
performance, drawing on skills honed
during a “misspent youth” singing in
folk clubs in the 1960s. “For this little
bald-headed man with glasses to walk
in holding a guitar is alone enough to
bring the house down,” Laskey wryly
remarks. “But then I sing a song that
mocks my own lectures.”
Entranced by cell biology even as
a schoolboy, he won a place at
Oxford to read zoology. John
Gurdon’s lectures were “unforgettably
good,” he remembers, and
Laskey stayed on to do a
PhD with Gurdon,
perfecting the nuclear
transplantation techniques
in frogs that are the
forerunners of today’s
cloning breakthroughs. He
moved to Lionel
Crawford’s laboratory at
the Imperial Cancer
Research Fund, where he
found another role model
for his scientific career. “Crawford
had a fantastic, but unobtrusive
influence on people’s careers. He just
encouraged rather than drove, and let
people develop their own ideas.”
Laskey’s PhD students soon
learn that they sink or swim largely
on their own efforts: Laskey has a
“very hands-off style of
supervision,” one former student
remembers, but is “very generous
with praise,” and has a gift for
building networks and sustaining
long-term collaborations. “He goes
out of his way to promote other
people’s careers, sometimes almost
to the point of embarrassment,” one
grateful colleague remembers.
In 1973 Laskey rejoined Gurdon,
this time at the MRC’s Molecular
Biology Unit in Cambridge, where
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he spent the next 10 years. His time
there culminated in a Cambridge
professorship, an FRS and latterly, a
directorship at the Wellcome-CRC
Institute in Cambridge. Some of his
most high-profile publications came
early on; two are among the all-time
100 most-cited papers. Driven by
curiosity, he spent a month scouring
the physics literature for a solution to
a problem he couldn’t solve, and so
devised a way to intensify the
imaging of radioisotope-labelled
DNA that has since become standard
practice throughout the world.
Throughout, his ambition has
been to develop a way of studying
DNA replication and protein
transport in cell-free systems. “Now
at last we can do it,” he says. “It
enables us to study the regulation of
DNA replication and also provides an
ethically clean system for screening
anti-cancer drugs.” The new cervical
cancer screening technique is another
spin-off from basic research:
proliferating cancerous cells are
identified by fluorescently labelled
antibodies against specific proteins
absent in quiescent cells but which
mark and identify unreplicated DNA
during cell division.
Accolades for his work continue
to roll in. Over the past 12 months or
so he has collected both the
Feldberg Prize and the Louis-Jeantet
Prize for Medicine, bringing in an
extra £250 000 for his laboratory. Yet
he still finds time to write and record
satirical Songs for Cynical Scientists,
including a lament to his chagrin at
having invented the term ‘molecular
chaperone’. “I am probably better
known — notorious, anyway — for
those songs than for the science,” he
says with a chuckle, and you suspect
that he is secretly quite pleased.
Gail Vines is a freelance science writer based
in Cambridge, UK.
The online version of this article (see
http://biomednet.com/cbiology/cub)
includes an excerpt from More Songs
for Cynical Scientists by Ron Laskey
(Cold Spring Harbor Press)
The fruit bodies of the mushroom
Coprinus cinereus mature rapidly; the
sequence of photographs in the main
picture above was taken over a
12-hour period (hence the Japanese
name, hi-to-yo-ta-ke, meaning
one-night mushroom).
The fruit-body primordium in the
image at top left is about 5 mm in
height. In the following two images,
meiosis is occurring — remarkably,
this is synchronous throughout the
cap. During sporulation, the pileus (a
specialised structure in which
nuclear fusion, meiosis and
sporulation occurs) turns black.
Because of its rapid development,
this fungus is an ideal organism for
studying mechanisms that govern
sexual development. Many of the
genes involved in fruiting have been
identified by means of mutations but
little is known of the molecular
mechanisms underlying
differentiation. For more details, see
Muraguchi H, Kamada T, Development
1998, 125:3133-3141.
Images provided by Takashi
Kamada, Department of Biology,
Faculty of Science, Okayama
University, Okayama 700-8530,
Japan. (Reproduced with permission
from Development.)
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